AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own CNA Financial, you have to be comfortable with a traditional insurance story where steady underwriting and investment income matter more than dramatic growth. The latest quarter fits that mindset: revenue and earnings ticked higher, and the company reaffirmed its US$0.48 quarterly dividend, suggesting no immediate pressure on capital returns. At the same time, net income for the first half of 2026 is below the prior year, so short term catalysts now hinge more on whether management can stabilise profitability than on top line progress. The mixed earnings trend slightly sharpens existing risks around earnings volatility and return on equity, while the recent share price giving back some near term gains implies the market sees the news as incremental rather than transformational.
However, one current risk that investors should not overlook relates directly to earnings quality and consistency. Despite retreating, CNA Financial's shares might still be trading 40% above their fair value. Discover the potential downside here.Explore another fair value estimate on CNA Financial - why the stock might be worth just $85.21!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com